Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Altered Expression of Gq/11α Protein Shapes mGlu1 and mGlu5 Receptor-Mediated Single Cell Inositol 1,4,5-Trisphosphate and Ca2+ Signaling

Peter J. Atkinson, Kenneth W. Young, Steven J. Ennion, James N. C. Kew, Stefan R. Nahorski and R. A. John Challiss
Molecular Pharmacology January 2006, 69 (1) 174-184; DOI: https://doi.org/10.1124/mol.105.014258
Peter J. Atkinson
Department of Cell Physiology & Pharmacology, University of Leicester, Leicester, United Kingdom (P.J.A., K.W.Y., S.J.E., S.R.N., R.A.J.C.); and Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, United Kingdom (J.N.C.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth W. Young
Department of Cell Physiology & Pharmacology, University of Leicester, Leicester, United Kingdom (P.J.A., K.W.Y., S.J.E., S.R.N., R.A.J.C.); and Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, United Kingdom (J.N.C.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven J. Ennion
Department of Cell Physiology & Pharmacology, University of Leicester, Leicester, United Kingdom (P.J.A., K.W.Y., S.J.E., S.R.N., R.A.J.C.); and Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, United Kingdom (J.N.C.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James N. C. Kew
Department of Cell Physiology & Pharmacology, University of Leicester, Leicester, United Kingdom (P.J.A., K.W.Y., S.J.E., S.R.N., R.A.J.C.); and Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, United Kingdom (J.N.C.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan R. Nahorski
Department of Cell Physiology & Pharmacology, University of Leicester, Leicester, United Kingdom (P.J.A., K.W.Y., S.J.E., S.R.N., R.A.J.C.); and Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, United Kingdom (J.N.C.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. A. John Challiss
Department of Cell Physiology & Pharmacology, University of Leicester, Leicester, United Kingdom (P.J.A., K.W.Y., S.J.E., S.R.N., R.A.J.C.); and Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, United Kingdom (J.N.C.K.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The metabotropic glutamate (mGlu) receptors mGlu1 and mGlu5 mediate distinct inositol 1,4,5-trisphosphate (IP3) and Ca2+ signaling patterns, governed in part by differential mechanisms of feedback regulation after activation. Single cell imaging has shown that mGlu1 receptors initiate sustained elevations in IP3 and Ca2+, which are sensitive to agonist concentration. In contrast, mGlu5 receptors are subject to cyclical PKC-dependent uncoupling and consequently mediate coincident IP3 and Ca2+ oscillations that are largely independent of agonist concentration. In this study, we investigated the contribution of Gq/11α protein expression levels in shaping mGlu1/5 receptor-mediated IP3 and Ca2+ signals, using RNA interference (RNAi). RNAi-mediated knockdown of Gq/11α almost abolished the single-cell increase in IP3 caused by mGlu1 and mGlu5 receptor activation. For the mGlu1 receptor, this unmasked baseline Ca2+ oscillations that persisted even at maximal agonist concentrations. mGlu5 receptor-activated Ca2+ oscillations were still observed but were only initiated at high agonist concentrations. Recombinant overexpression of Gqα enhanced IP3 signals after mGlu1 and mGlu5 receptor activation. It is noteworthy that although mGlu5 receptor-mediated IP3 and Ca2+ oscillations in control cells were largely insensitive to agonist concentration, increasing Gqα expression converted these oscillatory signatures to sustained plateau responses in a high proportion of cells. In addition to modulating temporal Ca2+ signals, up- or down-regulation of Gq/11α expression alters the threshold for the concentration of glutamate at which a measurable Ca2+ signal could be detected. These experiments indicate that altering Gq/11α expression levels differentially affects spatiotemporal aspects of IP3 and Ca2+ signaling mediated by the mGlu1 and mGlu5 receptors.

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 69 (1)
Molecular Pharmacology
Vol. 69, Issue 1
1 Jan 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Altered Expression of Gq/11α Protein Shapes mGlu1 and mGlu5 Receptor-Mediated Single Cell Inositol 1,4,5-Trisphosphate and Ca2+ Signaling
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Altered Expression of Gq/11α Protein Shapes mGlu1 and mGlu5 Receptor-Mediated Single Cell Inositol 1,4,5-Trisphosphate and Ca2+ Signaling

Peter J. Atkinson, Kenneth W. Young, Steven J. Ennion, James N. C. Kew, Stefan R. Nahorski and R. A. John Challiss
Molecular Pharmacology January 1, 2006, 69 (1) 174-184; DOI: https://doi.org/10.1124/mol.105.014258

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Altered Expression of Gq/11α Protein Shapes mGlu1 and mGlu5 Receptor-Mediated Single Cell Inositol 1,4,5-Trisphosphate and Ca2+ Signaling

Peter J. Atkinson, Kenneth W. Young, Steven J. Ennion, James N. C. Kew, Stefan R. Nahorski and R. A. John Challiss
Molecular Pharmacology January 1, 2006, 69 (1) 174-184; DOI: https://doi.org/10.1124/mol.105.014258
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
  • Benzbromarone Relaxes Airway Smooth Muscle via BK Activation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics